Results 111 to 120 of about 11,453 (268)

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source

Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome

São Paulo Medical Journal
CONTEXT AND OBJECTIVES: Glycoprotein inhibitors (abciximab, eptifibatide and tirofiban) are used in patients with unstable angina and non-ST-segment elevation myocardial infarction before percutaneous coronary intervention.
Antonio de Padua Mansur, Alessandra Roggerio, Júlio Yoshio Takada, Pérola Michelle Vasconcelos Caribé, Solange Desirée Avakian, Célia Maria Cassaro Strunz   +5 more
doaj   +1 more source

Desenlaces clínicos en una cohorte de pacientes con síndrome coronario agudo y administración intracoronaria de tirofiban

Revista Colombiana de Cardiología, 2015
Introducción: Los inhibidores de glicoproteína IIb/IIIa reducen los eventos cardiovasculares mayores adversos (MACE) en pacientes con síndrome coronario agudo.
Julián Ochoa, Jorge G. Velásquez, Jorge A. Cedano, Camila Ospina, Lina Merchancano, Diana C. Carrillo   +5 more
doaj   +1 more source

Preservación de la zona de penumbra en ictus isquémico embólico con Tirofibán en un modelo experimental [PDF]

, 2009
Existe un consenso mundial reconociendo la eficacia de la terapia de reperfusión, dentro de las primeras tres horas del evento, con el activador del plasminógeno tisular (tPA), de forma intravenosa.
Castaneda Vega, Salvador, Castillo Fuentes, Laura, Gómez Hernández, Jonathan   +2 more
core  

血小板麻酔 : ヒヒ体外循環中の可逆的血小板機能抑制の研究 [PDF]

, 1997
Thesis (Ph. D. in Medical Sciences)--University of Tsukuba, (B), no.
Hiramatsu Yuji, 平松 祐司
core  

Successful treatment of cardiogenic shock by stenting of the left main coronary artery in acute myocardial infarction [PDF]

, 2008
Introduction. Patients with non-ST elevation acute coronary syndromes (NSTE-ACS) are sometimes severely hemodynamicly compromised. Urgent coronary angiography should be performed in these patients in percutaneous coronary intervention (PCI) centers ...
Bošković Aneta, Dragnić Siniša, Knežević Božidarka, Musić Ljilja, Nikolić Goran   +4 more
core   +1 more source

Tirofiban for Cocaine-Induced Coronary Artery Thrombosis [PDF]

, 1999
Nikolaos G. Frangogiannis, John A. Farmer, Nasser Lakkis   +2 more
openalex   +1 more source

Anti-platelet therapy: ADP receptor antagonists. [PDF]

, 2011
The P2Y(12) receptor on platelets with which ADP interacts has an important role in promoting platelet function and thereby platelet involvement in both haemostasis and thrombosis.
Heptinstall, S, Wijeyeratne, YD
core   +2 more sources

TARGET: Do Tirofiban And ReoPro Give Similar Efficacy Trial? [PDF]

, 2000
Eric J. Topol
openalex   +1 more source

Tirofiban-Induced Thrombocytopenia Occurring with Crohn’s Disease

Case Reports in Cardiology, 2016
A 69-year-old man, with severe refractory Crohn’s disease, presented with acute coronary syndrome that required angioplasty. He developed severe tirofiban-induced thrombocytopenia (TIT) heralded by type I allergic reaction that required steroids and a combination of antihistamine H1 and antihistamine H2 for symptomatic management.
Fady El Karak, Assem Araji, Elie El Rassy, Toni Ibrahim   +3 more
openaire   +3 more sources